Atlas Trials

The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting

Clinical trial NCT03278262 · COMPLETED

Trial details

NCT number
NCT03278262
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Wet Macular Degeneration
Start date
2017-09-01
Primary completion
2017-12-31
Enrollment
2312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.